These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

451 related articles for article (PubMed ID: 19279389)

  • 1. The impact of first-trimester serum free beta-human chorionic gonadotropin and pregnancy-associated plasma protein A on the diagnosis of fetal growth restriction and small for gestational age infant.
    Montanari L; Alfei A; Albonico G; Moratti R; Arossa A; Beneventi F; Spinillo A
    Fetal Diagn Ther; 2009; 25(1):130-5. PubMed ID: 19279389
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Early fetal growth, PAPP-A and free β-hCG in relation to risk of delivering a small-for-gestational age infant.
    Kirkegaard I; Henriksen TB; Uldbjerg N
    Ultrasound Obstet Gynecol; 2011 Mar; 37(3):341-7. PubMed ID: 20737455
    [TBL] [Abstract][Full Text] [Related]  

  • 3. First-trimester biochemical markers of aneuploidy and the prediction of small-for-gestational age fetuses.
    Spencer K; Cowans NJ; Avgidou K; Molina F; Nicolaides KH
    Ultrasound Obstet Gynecol; 2008 Jan; 31(1):15-9. PubMed ID: 17999381
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association of extreme first-trimester free human chorionic gonadotropin-beta, pregnancy-associated plasma protein A, and nuchal translucency with intrauterine growth restriction and other adverse pregnancy outcomes.
    Krantz D; Goetzl L; Simpson JL; Thom E; Zachary J; Hallahan TW; Silver R; Pergament E; Platt LD; Filkins K; Johnson A; Mahoney M; Hogge WA; Wilson RD; Mohide P; Hershey D; Wapner R;
    Am J Obstet Gynecol; 2004 Oct; 191(4):1452-8. PubMed ID: 15507982
    [TBL] [Abstract][Full Text] [Related]  

  • 5. First trimester maternal serum PAPP-A, beta-hCG and ADAM12 in prediction of small-for-gestational-age fetuses.
    Pihl K; Larsen T; Krebs L; Christiansen M
    Prenat Diagn; 2008 Dec; 28(12):1131-5. PubMed ID: 19003798
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The impact of assisted reproductive technology on the association between first-trimester pregnancy-associated plasma protein a and human chorionic gonadotropin and adverse pregnancy outcomes.
    Zhong Y; Bradshaw R; Stanley AP; Odibo AO
    Am J Perinatol; 2011 May; 28(5):347-54. PubMed ID: 21082535
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Correlation of first-trimester serum levels of pregnancy-associated plasma protein A with small-for-gestational-age neonates and preterm births.
    Gundu S; Kulkarni M; Gupte S; Gupte A; Gambhir M; Gambhir P
    Int J Gynaecol Obstet; 2016 May; 133(2):159-63. PubMed ID: 26892697
    [TBL] [Abstract][Full Text] [Related]  

  • 8. First trimester maternal serum PAPP-A and free β-hCG levels and risk of SGA or LGA in women with and without GDM.
    Kantomaa T; Vääräsmäki M; Gissler M; Ryynänen M; Nevalainen J
    BMC Pregnancy Childbirth; 2024 Sep; 24(1):580. PubMed ID: 39242998
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Screening for trisomy 21 by fetal tricuspid regurgitation, nuchal translucency and maternal serum free beta-hCG and PAPP-A at 11 + 0 to 13 + 6 weeks.
    Falcon O; Auer M; Gerovassili A; Spencer K; Nicolaides KH
    Ultrasound Obstet Gynecol; 2006 Feb; 27(2):151-5. PubMed ID: 16388509
    [TBL] [Abstract][Full Text] [Related]  

  • 10. First trimester maternal serum analytes and second trimester uterine artery Doppler in the prediction of preeclampsia and fetal growth restriction.
    Yu N; Cui H; Chen X; Chang Y
    Taiwan J Obstet Gynecol; 2017 Jun; 56(3):358-361. PubMed ID: 28600048
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The efficacy of first-trimester PAPP-A and free beta hCG levels for predicting adverse pregnancy outcome.
    Kavak ZN; Basgul A; Elter K; Uygur M; Gokaslan H
    J Perinat Med; 2006; 34(2):145-8. PubMed ID: 16519620
    [TBL] [Abstract][Full Text] [Related]  

  • 12. First-trimester maternal serum PAPP-A and free-beta subunit human chorionic gonadotropin concentrations and nuchal translucency are associated with obstetric complications: a population-based screening study (the FASTER Trial).
    Dugoff L; Hobbins JC; Malone FD; Porter TF; Luthy D; Comstock CH; Hankins G; Berkowitz RL; Merkatz I; Craigo SD; Timor-Tritsch IE; Carr SR; Wolfe HM; Vidaver J; D'Alton ME
    Am J Obstet Gynecol; 2004 Oct; 191(4):1446-51. PubMed ID: 15507981
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prediction of birth weight by fetal crown-rump length and maternal serum levels of pregnancy-associated plasma protein-A in the first trimester.
    Leung TY; Sahota DS; Chan LW; Law LW; Fung TY; Leung TN; Lau TK
    Ultrasound Obstet Gynecol; 2008 Jan; 31(1):10-4. PubMed ID: 18098339
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Maternal serum free-beta-chorionic gonadotrophin, pregnancy-associated plasma protein-A and fetal nuchal translucency thickness at 10-13(+6) weeks in relation to co-variables in pregnant Saudi women.
    Ardawi MS; Nasrat HA; Rouzi AA; Qari MH; Al-Qahtani MH; Abuzenadah AM
    Prenat Diagn; 2007 Apr; 27(4):303-11. PubMed ID: 17269128
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prediction of small-for-gestational-age neonates: screening by maternal biochemical markers at 30-34 weeks.
    Bakalis S; Gallo DM; Mendez O; Poon LC; Nicolaides KH
    Ultrasound Obstet Gynecol; 2015 Aug; 46(2):208-15. PubMed ID: 25826797
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Performance of third-trimester ultrasound for prediction of small-for-gestational-age neonates and evaluation of contingency screening policies.
    Souka AP; Papastefanou I; Pilalis A; Michalitsi V; Kassanos D
    Ultrasound Obstet Gynecol; 2012 May; 39(5):535-42. PubMed ID: 21858886
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prediction of pregnancy complications by first-trimester maternal serum PAPP-A and free beta-hCG and with second-trimester uterine artery Doppler.
    Spencer K; Yu CK; Cowans NJ; Otigbah C; Nicolaides KH
    Prenat Diagn; 2005 Oct; 25(10):949-53. PubMed ID: 16086443
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association between birth weight and first-trimester free beta-human chorionic gonadotropin and pregnancy-associated plasma protein A.
    Canini S; Prefumo F; Pastorino D; Crocetti L; Afflitto CG; Venturini PL; De Biasio P
    Fertil Steril; 2008 Jan; 89(1):174-8. PubMed ID: 17509577
    [TBL] [Abstract][Full Text] [Related]  

  • 19. First-trimester screening for trisomy 21 by free beta-human chorionic gonadotropin and pregnancy-associated plasma protein-A: impact of maternal and pregnancy characteristics.
    Kagan KO; Wright D; Spencer K; Molina FS; Nicolaides KH
    Ultrasound Obstet Gynecol; 2008 May; 31(5):493-502. PubMed ID: 18432600
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prediction of small-for-gestational-age neonates: screening by maternal serum biochemical markers at 19-24 weeks.
    Lesmes C; Gallo DM; Gonzalez R; Poon LC; Nicolaides KH
    Ultrasound Obstet Gynecol; 2015 Sep; 46(3):341-9. PubMed ID: 25969963
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.